Poland· PL-100453950

Ansifora

A sitagliptin product containing sitagliptinum, registered in Poland by Vipharm S.A.. The same ATC class is registered in 19 of our 19 countries.

ATC A10BH01

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sitagliptinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Sitagliptin is registered in 19 of 19 countries.

Countries holding a registration under ATC A10BH01 (sitagliptin), each read from that country’s own register.

This record: Poland, from URPL (Poland)
11 of them publish a price we can compare per daily dose

Search sitagliptin products by name

Sitagliptin · ATC A10BH01

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sitagliptin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.65 in France to $5.47 in Switzerland — a ×8.4 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Sitagliptin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

CH Switzerland$5.47
IT Italy$1.78
ES Spain$1.08
FR France$0.65

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Sitagliptinum
Manufacturer: Vipharm S.A.
Country: Poland (PL)
ATC code: A10BH01
ATC class: Sitagliptin
Defined daily dose: 0.1 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 14

1 priced

gtin
05901812162564
28 szt.
PLN 29.39
gtin
05901812162748
gtin
05901812162557
gtin
05901812162618
gtin
05901812162700
gtin
05901812162731
gtin
05901812162588
gtin
05901812162595
gtin
05901812162717
gtin
05901812162571
gtin
05901812162601
gtin
05901812162755
gtin
05901812162724
gtin
05901812162694

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

341 interactions on record for sitagliptin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check sitagliptin against other medicines How interaction checks work

Sitagliptin · interactions on record

341 records

3 severe
292 moderate
44 minor

Most severe, free to view

GatifloxacinJ01MA16severe
SucralfateA02BX02moderate
ThiethylperazinA04AB03moderate
TriflupromazinA04AD06moderate

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sitagliptin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sitagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Jansitin, Jazeta
Belgium · Sitagliptin Eg, Sitagliptin Grindeks
Bulgaria · Sitagliptin Grindeks, Майсиглу
Cyprus · Jidinum, Jimandin
Czechia · Anau, Ansifora
Germany · Frekidir, Jansitin
Denmark · Frekidir, Meliglix
Estonia · Adimuplan, Maysiglu
Spain · Altuxerin, Disit
Finland · Sitagliptin Apc Instytut, Sitagliptin Ashcure
France · Sitagliptine Adamed, Sitagliptine Almus
United Kingdom (Northern Ireland) · Sitagliptin, Sitagliptin Amarox
Greece · Adimuplan, Axavel
Croatia · Adimuplan, Condias
Hungary · Ansifora, Jaglix
Ireland · Sitagliptin Grindeks, Sitagliptin Krka
Iceland · Januvia, Ristaben
Italy · Adaglip, Andamane
Liechtenstein · Januvia, Ristaben
Lithuania · Adimuplan, Jimandin
Luxembourg · Sitagliptin Eg
Latvia · Adimuplan, Jimandin
Malta · Anau, Jidinum
Netherlands · Adimuplan, Anau
Norway · Frekidir, Januvia
Portugal · Itam, Jidinum
Romania · Adimuplan, Jansitin
Sweden · Axavel, Frekidir
Slovenia · Adimuplan, Maysiglu
Slovakia · Adimuplan, Anau

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bb1fee55-91ea-460d-9162-b0576d5346e7
GET /v1/drugs/bb1fee55-91ea-460d-9162-b0576d5346e7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "100 mg",
  "packaging": "05901812162595 ¦ Rp ¦ 148233\n84 tabl.\n05901812162564 ¦ Rp ¦ 148234\n28 tabl.\n05901812162717 ¦ Rp ¦ 148235\n30 tabl.\n05901812162571 ¦ Rp ¦ 148236\n30 tabl.\n05901812162601 ¦ Rp ¦ 148237\n90 tabl.\n05901812162755 ¦ Rp ¦ 148238\n98 tabl.\n05901812162724 ¦ Rp ¦ 148239\n56 tabl.\n05901812162694 ¦ Rp ¦ 148240\n14 tabl.\n05901812162748 ¦ Rp ¦ 148241\n90 tabl.\n05901812162557 ¦ Rp ¦ 148242\n14 tabl.\n05901812162618 ¦ Rp ¦ 148243\n98 tabl.\n05901812162700 ¦ Rp ¦ 148244\n28 tabl.\n05901812162731 ¦ Rp ¦ 148245\n84 tabl.\n05901812162588 ¦ Rp ¦ 148246\n56 tabl.",
  "substance": "Sitagliptini hydrochloridum monohydricum 113.38 mg",
  "common_name": "Sitagliptinum",
  "pl_product_id": "100453950",
  "pozwolenie_nr": "27567",
  "auth_procedure": "DCP",
  "authorisation_validity": "2027-12-21"
}

API reference MCP server Plans

See everything about sitagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console